Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

ARCH Overage Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$50M
Portfolio companies 3
Lead investments 0
Exits 3
Key employees Soon

Areas of investment

  • Biotechnology
  • Life Science
  • Health Care
  • Chemical
  • Pharmaceutical
Summary

Among the most popular portfolio startups of the fund, we may highlight Twist Bioscience, Homology Medicines, Quanterix. The fund has exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Genetics, Analytics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2016. Opposing the other organizations, this ARCH Overage Fund works on 71 percentage points more the average amount of lead investments.

The typical case for the fund is to invest in rounds with 7-8 participants. Despite the ARCH Overage Fund, startups are often financed by ARCH Venture Partners, Tao Venture Partners, Paladin Capital Group. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Cormorant Asset Management, WuXi Healthcare Ventures. In the next rounds fund is usually obtained by Vivo Capital, Vida Ventures, Temasek Holdings.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of ARCH Overage Fund:
1 ARCH Venture Partners
2 Fidelity Management and Research Company
3 Tao Venture Partners
Typical Co-investors
ARCH Overage Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after ARCH Overage Fund:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
Fund NameLocation
Bayshore HealthCare Canada, Mississauga, Ontario
BeGreat -
BHI -
InsurTech Gateway England, London, United Kingdom
Next 10 Ventures California, Los Angeles, United States
Oltre Venture Italy, Lombardy, Milan
OSF HealthCare Illinois, Peoria, United States
RainmakeMe New York, New York, United States
Ubiquity Ventures California, Palo Alto, United States
W ventures Japan Japan, Kanagawa Prefecture, Kawasaki

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Homology Medicines

Alternative Medicine
Biotechnology
Genetics
Health Care
$43M02 May 2016
Temasek Holdings
5AM Ventures
ARCH Overage Fund
Deerfield
ARCH Venture Partners
 Massachusetts, United States
By posting comments on our website you confirm and acknowledge that:

1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.

2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.

3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.

4. We can moderate comments at any time.

5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.

6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.

Agree

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent ARCH Overage Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 50M
Peak activity year 2016
Lead investments 0
Exits 3
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Homology Medicines

Alternative Medicine
Biotechnology
Genetics
Health Care
$43M02 May 2016
Temasek Holdings
5AM Ventures
ARCH Overage Fund
Deerfield
ARCH Venture Partners
 Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors:

Send